AKT London has raised $7 million in a Series A funding round led by Felix Capital to accelerate expansion. This brings its total funding raised to $10 million since 2020.WHO: Founded by West End performers Andy Coxon and Ed Currie in 2020, AKT London has rapidly gained a loyal following in the UK for its innovative, gender-neutral deodorant balms. The brand, born out of a desire to create a deodorant that could withstand the demands of life onstage, has garnered praise for its commitment to sustainability, efficacy, and luxurious scents. The multiuse deodorant balm comes in three fine fragrances inspired by nature, and is applied using a brass applicator that takes inspiration from gua sha, a traditional Chinese healing method. The brand launched with a DTC subscription model but is also carried at John Bell & Croyden.WHY: The investment will be used to advance AKT's product innovation,  expansion in the United States, and retailer expansion.IN THEIR OWN WORDS: Andy Coxon and Ed Currie, founders of AKT London, said, “From the moment we met the team at Felix we felt like they were the right partners for us: they really understand the importance of creativity, story-telling and sustainability, which is everything we are about at AKT London. We are excited to be joining an impressive portfolio of brands like, Ami, Goop, Our Place, and Lick as we scale the brand across the US, helping customers to make better choices for their environment and bodies—all the while helping them to smell fresh all day! We are excited to grow the brand, alongside Felix, across the US in high-end stores, as well launching new products in 2025. Let’s get this show on the road!